Avrobio Inc (AVRO)
1.19
-0.02
(-1.65%)
USD |
NASDAQ |
Apr 24, 16:00
1.19
0.00 (0.00%)
Pre-Market: 20:00
Avrobio Price: 1.19 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 1.19 | 1.21 | 1.185 | 1.19 | 348448.0 |
Apr 23, 2024 | 1.20 | 1.23 | 1.18 | 1.21 | 53884.00 |
Apr 22, 2024 | 1.18 | 1.22 | 1.18 | 1.20 | 52538.00 |
Apr 19, 2024 | 1.227 | 1.23 | 1.195 | 1.20 | 39507.00 |
Apr 18, 2024 | 1.24 | 1.26 | 1.22 | 1.24 | 36535.00 |
Apr 17, 2024 | 1.25 | 1.265 | 1.20 | 1.22 | 203387.0 |
Apr 16, 2024 | 1.25 | 1.27 | 1.24 | 1.26 | 183989.0 |
Apr 15, 2024 | 1.28 | 1.28 | 1.242 | 1.26 | 203318.0 |
Apr 12, 2024 | 1.24 | 1.29 | 1.24 | 1.27 | 56543.00 |
Apr 11, 2024 | 1.25 | 1.29 | 1.25 | 1.27 | 140913.0 |
Apr 10, 2024 | 1.26 | 1.27 | 1.24 | 1.25 | 81039.00 |
Apr 09, 2024 | 1.258 | 1.28 | 1.24 | 1.26 | 92360.00 |
Apr 08, 2024 | 1.26 | 1.27 | 1.23 | 1.26 | 107823.0 |
Apr 05, 2024 | 1.31 | 1.31 | 1.25 | 1.27 | 83205.00 |
Apr 04, 2024 | 1.30 | 1.31 | 1.27 | 1.31 | 160282.0 |
Apr 03, 2024 | 1.26 | 1.31 | 1.255 | 1.30 | 155865.0 |
Apr 02, 2024 | 1.25 | 1.29 | 1.22 | 1.28 | 135543.0 |
Apr 01, 2024 | 1.28 | 1.30 | 1.26 | 1.28 | 59242.00 |
Mar 28, 2024 | 1.259 | 1.30 | 1.25 | 1.28 | 104197.0 |
Mar 27, 2024 | 1.25 | 1.265 | 1.22 | 1.26 | 423615.0 |
Mar 26, 2024 | 1.25 | 1.27 | 1.22 | 1.26 | 69151.00 |
Mar 25, 2024 | 1.21 | 1.25 | 1.15 | 1.22 | 812323.0 |
Mar 22, 2024 | 1.25 | 1.29 | 1.23 | 1.28 | 46202.00 |
Mar 21, 2024 | 1.26 | 1.28 | 1.23 | 1.25 | 77122.00 |
Mar 20, 2024 | 1.26 | 1.29 | 1.240 | 1.28 | 183970.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.578
Minimum
May 17 2023
27.21
Maximum
Feb 11 2020
8.096
Average
5.58
Median
Sep 30 2021
Price Benchmarks
Axonics Inc | 66.64 |
Catalent Inc | 55.95 |
AIM ImmunoTech Inc | 0.43 |
Protalix BioTherapeutics Inc | 1.21 |
Armata Pharmaceuticals Inc | 2.50 |
Price Related Metrics
PE Ratio | 4.407 |
Price to Book Value | 0.5637 |
Earnings Yield | 22.69% |
Market Cap | 53.40M |